المؤلفون: Marta Trapero Bertran, Max Brosa Riestra, Jaime Espín Balbino, Juan Oliva, Key4Value-Grupo II

المصدر: Revista Española de Salud Pública, Vol 89, Iss 2, Pp 125-135 (2015)

مصطلحات موضوعية: Medicine, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: http://www.redalyc.org/articulo.oa?id=17036224002; https://doaj.org/toc/1135-5727; https://doaj.org/toc/2173-9110

URL الوصول: https://doaj.org/article/8e5decfa6b8c457a8f8077eb6d310ea7

المؤلفون: Juan Bautista Galdiz-Iturri, Montse Figueras-Sabaté, Ferran Pérez-Alcántara, Luis Borderías-Clau, Max Brosa-Riestra, Maribel Riera-Febrer

المصدر: PharmacoEconomics Spanish Research Articles. 10:89-97

مصطلحات موضوعية: Health Policy, Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bea7c91f3b1d02f7538ea436e5f1a67f
https://doi.org/10.1007/s40277-013-0011-x

المؤلفون: José Rodríguez Barrios, Ferran Pérez Alcántara, Carlos Crespo Palomo, Paloma González García, Enrique Antón De Las Heras, Max Brosa Riestra

المصدر: Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), The European Journal of Health Economics. 13(6):723-740

الإتاحة: https://ideas.repec.org/a/spr/eujhec/v13y2012i6p723-740.html

المؤلفون: Laura García-Bujalance, Diana Nieves Calatrava, Antonio Rivero-Román, Isabel Pérez-Escolano, Oscar de la Calle-Martin, José A. Iribarren-Loyarte, Max Brosa-Riestra

المصدر: Enfermedades Infecciosas y Microbiología Clínica. 28:590-595

مصطلحات موضوعية: Microbiology (medical), Marginal cost, medicine.medical_specialty, Cost–benefit analysis, Anti-HIV Agents, Cost effectiveness, business.industry, Cost-Benefit Analysis, Cost-effectiveness analysis, Dideoxynucleosides, Drug Hypersensitivity, Models, Economic, Pharmacotherapy, HLA-B Antigens, Spain, Abacavir, Internal medicine, HIV Seropositivity, Cohort, medicine, Humans, Adverse effect, business, health care economics and organizations, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772f4c9a34ae74631784618bc25acc52
https://doi.org/10.1016/j.eimc.2009.09.010

المؤلفون: Max Brosa-Riestra, Miguel-Ángel Seguí-Palmer, Miguel Martín-Jiménez, Manuel Ruiz-Borrego, Álvaro Rodríguez-Lescure

المصدر: Clinical and Translational Oncology. 11:41-47

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Cyclophosphamide, Cost effectiveness, Cost-Benefit Analysis, Breast Neoplasms, Docetaxel, law.invention, Breast cancer, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Doxorubicin, business.industry, Standard treatment, General Medicine, medicine.disease, Surgery, Models, Economic, Fluorouracil, Female, Taxoids, Quality-Adjusted Life Years, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df8c94a565472cf4f33a9ca41b0bb8ee
https://doi.org/10.1007/s12094-009-0309-y

المؤلفون: Jaime, Espín Balbino, Max, Brosa Riestra, Juan, Oliva Moreno, Marta, Trapero-Bertran, Sánchez I, Sánchez

المصدر: Revista espanola de salud publica. 89(3)

مصطلحات موضوعية: Terminal Care, Rare Diseases, Spain, Cost-Benefit Analysis, Outcome Assessment, Health Care, Humans, Health Care Costs

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::578a2535c9c6535edaf4d6c1b7988aad
https://pubmed.ncbi.nlm.nih.gov/26388338

المؤلفون: Marta, Trapero-Bertran, Max, Brosa Riestra, Jaime, Espín Balbino, Juan, Oliva, Joan Ramón, Villalbí

المصدر: Revista espanola de salud publica. 89(2)

مصطلحات موضوعية: Spain, Cost-Benefit Analysis, Outcome Assessment, Health Care, Quality of Life, Humans, Health Care Costs

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::e7b95510d7860bfd835480d8e556bfe1
https://pubmed.ncbi.nlm.nih.gov/26121623

المؤلفون: Max Brosa Riestra, Jaime Espín Balbino, Marta Trapero-Bertran, Juan Oliva Moreno

المساهمون: Key4Value-Grupo III, [Espín Balbino,J] Escuela Andaluza de Salud Pública, Granada. [Brosa Riestra,M] Oblikue Consulting, Barcelona. [Oliva Moreno,J, Trapero-Bertran,M] Universidad de Castilla La Mancha. [Trapero-Bertran,M] Universitat Pompeu Fabra, Barcelona., El proyecto Key4Value ha sido financiado por Novartis Farmacéutica

المصدر: Revista Española de Salud Pública v.89 n.3 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Recercat. Dipósit de la Recerca de Catalunya

مصطلحات موضوعية: Outcome assessment (Health Care), Health Care::Health Services Administration::Patient Care Management::Delivery of Health Care [Medical Subject Headings], Consensus, Cost, Economics, Research areas, Psychological intervention, Evaluación de resultados, Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Thinking::Decision Making [Medical Subject Headings], Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Rare Diseases [Medical Subject Headings], Bioètica, Economía, Health Care::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis [Medical Subject Headings], Political science, Health care, Methods, Terminal care, Costes, Costos de la Atención en Salud, Costos de la atención en salud, Reimbursement, Disciplines and Occupations::Natural Science Disciplines::Science::Research [Medical Subject Headings], business.industry, Enfermedades raras, Welfare economics, Methodology, Economía y organización de los cuidados de salud, General Medicine, Bioethics, Metodología, Costs, Rare diseases, Medicamentos huérfanos, Health care economics and organizations, Identification (information), Cuidado terminal, Consenso, Economic evaluation, Health care costs, business, Bioética, Externality, Orphan drugs production

وصف الملف: text/html; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3364eff9dba5c1d326a2ed2a70452b10
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272015000300002

المؤلفون: Paloma González García, Ferran Pérez Alcántara, Enrique Antón De Las Heras, José Manuel Rodríguez Barrios, Max Brosa Riestra, Carlos Crespo Palomo

المساهمون: Universitat de Barcelona

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Health economics, Actuarial science, Cost effectiveness, business.industry, Health Policy, media_common.quotation_subject, Cost-Benefit Analysis, Economics, Econometrics and Finance (miscellaneous), MEDLINE, Biomedical Technology, Economic analysis, Quality-adjusted life year, Spain, Health care, Economic evaluation, Medical economics, Medicine, Anàlisi econòmica, Quality (business), Quality-Adjusted Life Years, Espanya, Methodological quality, business, Economia de la salut, media_common

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c7c9c9abd3b0710c9a384203a30db10
http://hdl.handle.net/2445/44707

المؤلفون: Diana Nieves Calatrava, Isabel Pérez-Escolano, Laura García-Bujalance, Antonio Rivero-Román, José A. Iribarren-Loyarte, Max Brosa-Riestra, Oscar de la Calle-Martin

المصدر: Enfermedades Infecciosas y Microbiología Clínica. 30:356

مصطلحات موضوعية: Microbiology (medical), business.industry, Abacavir, Immunology, Hiv patients, Medicine, Typing, Cost-effectiveness analysis, business, Hla b 5701, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6b2a173d62ebf1692fcd39563d48d5e4
https://doi.org/10.1016/j.eimc.2011.10.010